Log In
Print this Print this

Envarsus, tacrolimus (formerly LCP-Tacro)

  Manage Alerts
Collapse Summary General Information
Company Veloxis Pharmaceuticals A/S
DescriptionOnce-daily tablet formulation of tacrolimus delivered using the MeltDose technology
Molecular Target FK506 binding protein (macrophilin-12)
Mechanism of ActionCalcineurin inhibitor
Therapeutic ModalityMacrocycle

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today